TerrAscend (OTCMKTS:TSNDF – Get Free Report) is one of 43 public companies in the “Agricultural production – crops” industry, but how does it weigh in compared to its rivals? We will compare TerrAscend to similar companies based on the strength of its valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.
Institutional & Insider Ownership
5.8% of TerrAscend shares are held by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are held by institutional investors. 31.9% of TerrAscend shares are held by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares TerrAscend and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
TerrAscend | -23.95% | -31.48% | -11.40% |
TerrAscend Competitors | -98.15% | -2,439.03% | -14.56% |
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
TerrAscend | 0 | 1 | 0 | 1 | 3.00 |
TerrAscend Competitors | 314 | 258 | 604 | 34 | 2.30 |
As a group, “Agricultural production – crops” companies have a potential upside of 54.91%. Given TerrAscend’s rivals higher probable upside, analysts plainly believe TerrAscend has less favorable growth aspects than its rivals.
Risk & Volatility
TerrAscend has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s rivals have a beta of -19.60, meaning that their average stock price is 2,060% less volatile than the S&P 500.
Valuation and Earnings
This table compares TerrAscend and its rivals gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
TerrAscend | $317.33 million | -$95.54 million | -1.60 |
TerrAscend Competitors | $1.22 billion | -$827,419.35 | 6.85 |
TerrAscend’s rivals have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Summary
TerrAscend beats its rivals on 7 of the 13 factors compared.
TerrAscend Company Profile
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.